Guizhou Xinbang Pharmaceutical Co.,Ltd.’s Net Profit Rose 22.8% in First Half of 2023

Guizhou Xinbang Pharmaceutical Co.,Ltd. (贵州信邦制药股份有限公司) (002390.SZ) reported a net profit of 191.6 million yuan in the first half of 2023, up 22.8% year-on-year.

Meanwhile, the company posted 3.3 billion yuan in revenue, up 3.6% year-on-year.

At the end of the reporting period, it had 9.7 billion yuan in total assets and 2.6 billion yuan in total liabilities, with a liability-to-asset ratio of 26.5%.